Royalty Pharma PLC (Class A)

2026-11-12 20:36; UTC

Shares of Royalty Pharma PLC are declining after the company raised its 2026 guidance, despite a clinical setback for Pelacarsen.

2026-11-11 23:16; UTC

Royalty Pharma PLC is trading roughly flat in after-market hours, recovering slightly from an earlier low amid strong monthly performance.

2026-11-10 21:07; UTC

Royalty Pharma PLC shares are modestly higher, reaching the upper end of their one-month range as the broader market nears 1% cumulative returns since Monday.

2026-11-09 21:03; UTC

Royalty Pharma PLC shares are rising amid high trading volume, having advanced since Friday and trading well above its 20-day moving average.

2026-11-06 22:51; UTC

Royalty Pharma PLC shares advanced in after-hours trading, reaching a peak return amid strong performance and significantly above their 20-day moving average.

2026-11-05 21:08; UTC

Royalty Pharma PLC traded near unchanged, retracing from a notable high reached earlier in the session, while remaining above its 20-day moving average.

2026-11-04 21:04; UTC

Royalty Pharma PLC raised its full-year 2026 guidance for portfolio receipts to $3.50B-$3.55B after reporting strong Q3 results with $890M in receipts.

2026-11-03 21:07; UTC

Royalty Pharma PLC shares are declining, pulling back from an earlier gain but remaining above the 20-day moving average and near the upper end of its one-month range.

2026-10-30 20:03; UTC

Royalty Pharma PLC shares are advancing, significantly above their 20-day moving average and near the upper end of their one-month range.

2026-10-29 20:07; UTC

Royalty Pharma PLC shares are higher, supported by strong momentum in the broader market and gains in key holdings within the XLV ETF during earnings season.

2026-10-28 20:07; UTC

Royalty Pharma PLC shares are declining, following a broader market trend lower since Tuesday, despite stabilizing somewhat after an earlier drop.

2026-10-27 20:01; UTC

Royalty Pharma PLC is trading modestly higher, supported by a notable increase in market volume and remaining significantly above its 20-day moving average.

2026-10-26 22:16; UTC

Royalty Pharma PLC is trading modestly higher in after-market hours, continuing its performance from Monday's close and remaining well above its 20-day moving average.

2026-10-23 20:07; UTC

Shares of Royalty Pharma PLC are advancing, showing a slight gain since Thursday's close and recovering to near its highest point during Friday's trading session.

2026-10-22 20:02; UTC

Royalty Pharma PLC is gaining amid a broader market downturn, diverging from the recent upward momentum observed in prior sessions.

2026-10-21 20:41; UTC

Royalty Pharma PLC is experiencing a notable decline in after-market trading, moving lower since Wednesday's close and trading at the lower end of today's range.

2026-10-20 22:46; UTC

Royalty Pharma PLC's shares advanced in after-market hours on Tuesday, remaining just above the previous close and 7.13% above its 20-day moving average.

2026-10-19 20:07; UTC

Royalty Pharma PLC shares are declining, hitting a midday low after an early peak.

2026-10-16 20:02; UTC

Royalty Pharma PLC declared a quarterly dividend of $0.235 per Class A share, payable on December 10, 2026, to shareholders of record as of November 13, 2026.

2026-10-15 20:07; UTC

Royalty Pharma PLC shares advanced, supported by broader market strength, while the Health Care Select Sector SPDR ETF reached a record high.

2026-10-14 20:02; UTC

Royalty Pharma PLC is advancing during Wednesday's market hours, continuing its upward trajectory since Tuesday's close with unusually high trading volume.

2026-10-13 20:02; UTC

Royalty Pharma PLC shares fell sharply, trading near the low end of their one-month range after an initial rebound earlier in the session.

2026-10-12 20:06; UTC

Royalty Pharma PLC is advancing, reflecting a strong performance since Friday's close, with today's price peaking in the early afternoon before settling slightly lower.

2026-10-09 21:01; UTC

Royalty Pharma PLC shares traded lower in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

2026-10-08 20:13; UTC

Royalty Pharma PLC shares advanced modestly during after-market hours on Thursday, holding steady with no notable fluctuations since the market closed.

2026-10-07 19:35; UTC

Royalty Pharma PLC shares advanced modestly after Morgan Stanley raised its price target to $67.00 from $65.00 while maintaining an Overweight rating.

2026-10-06 20:12; UTC

Royalty Pharma PLC is trading modestly higher in after-market hours, maintaining a steady position below its 20-day moving average and near the lower end of its one-month range.

2026-10-05 20:02; UTC

Royalty Pharma PLC shares fell sharply, continuing a downward trend amid broader pharmaceutical sector weakness and reflecting unusually high market volume.

2026-10-02 20:07; UTC

Royalty Pharma PLC shares fell sharply, continuing a downward trend and hitting a session low just before market close, significantly below its 20-day moving average.

2026-10-01 20:07; UTC

Royalty Pharma PLC shares fell sharply, remaining below their 20-day moving average and positioned near the lower end of their one-month range.